Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2022 | Story Lacea Loader

On 14 March 2022, the Bloemfontein and Qwaqwa Campuses of the University of the Free State (UFS) will return to face-to-face classes as per the teaching plans for 2022. The faculties that are continuing with face-to-face classes in the first term (i.e., the Faculties of Natural and Agricultural Sciences and Health Sciences), will remain face-to-face during the week of 7 to 11 March 2022.

The decision to resume face-to-face classes follows previous communiques in February 2022 about the temporary closure of the Qwaqwa Campus due to violent protest action, and the continuation of the academic programme on the Bloemfontein Campus in a differentiated and flexible online delivery mode due to challenges experienced with disruption of classes. 
 
The return to face-to-face classes on 14 March 2022 also follows the reopening of and resumption of online classes on the Qwaqwa Campus on 28 February 2022, and the resumption of some face-to-face activity on the Qwaqwa Campus as from 7 March 2022.

As a residential institution, it is important for students to return to campus, for the academic programme to continue as planned, and for activities to return to normal.
 
Students will be informed by their respective faculties as to how the academic programme will be adapted for face-to-face classes, including instances where classes will remain online.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept